TDSPHARM Co., Ltd. Logo

TDSPHARM Co., Ltd.

Develops and manufactures transdermal drug delivery systems like patches, plasters, and OTC products.

464280 | KO

Overview

Corporate Details

ISIN(s):
KR7464280007
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 253 C동 403호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TDSPHARM Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Transdermal Drug Delivery Systems (TDDS). Founded in 2002, the company leverages its expertise in TDDS technology to produce a range of products, including medical cataplasmas, plasters, and patches. Its portfolio also encompasses over-the-counter (OTC) medicines and cosmetic products. The company is committed to R&D to deliver safe and efficient medicinal products that are absorbed through the skin, with a goal of providing accessible healthcare solutions to consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 86.7 KB
2025-09-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 814.7 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 783.5 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.0 KB
2025-04-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.5 KB
2025-04-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 90.5 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.6 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 18.0 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 437.1 KB
2025-03-17 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1013.2 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 101.9 KB
2025-02-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.1 KB

Automate Your Workflow. Get a real-time feed of all TDSPHARM Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TDSPHARM Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TDSPHARM Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PureTech Health plc Logo
A clinical-stage biotherapeutics firm developing new medicines for devastating diseases.
United States of America
PRTC
PURPLE BIOTECH LTD. Logo
Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.
United States of America
PPBT
Pyxis Oncology, Inc. Logo
Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.
United States of America
PYXS
PZ Cormay S.A. Logo
Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.
Poland
CRM
Q32 Bio Inc. Logo
Clinical-stage biotech developing biologic therapies for autoimmune and inflammatory diseases.
United States of America
QTTB
Quantum Biopharma Ltd. Logo
Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.
United States of America
QNTM
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France
ALQGC
QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America
QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America
QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America
QNRX

Talk to a Data Expert

Have a question? We'll get back to you promptly.